(Please note, this Podcast was created using generative AI (GenAI), and while our Partners review and edit it for quality purposes, GenAI can sometimes make mistakes. This Podcast is for educational and entertainment purposes only. Please consult source materials directly and seek professional advice when needed.) 

This podcast delves into the critical findings of the 2025 Edelman Trust Barometer Report, specifically examining its implications for the pharmaceutical and biotech industries. It explores the current climate of global grievance and widespread distrust in institutions, and how this impacts the ability of pharma and biotech companies to operate effectively.

Key topics discussed include the erosion of employee trust in CEOs, the rising fear of discrimination and its potential consequences, and the urgent need for these industries to earn and maintain public trust – their "license to act". The podcast emphasises that traditional approaches focused solely on profit are no longer sufficient, and highlights the expectation for businesses to actively address societal concerns. 

Listeners will gain insights into the importance of transparency, accountability, and ethical conduct as cornerstones of trust-building. The podcast also offers concrete, actionable steps that leaders in risk, compliance, and audit can take within their organisations to foster a culture of trust and navigate this challenging landscape. It underscores the evolving role of CEOs as societal leaders and the necessity of a company-wide commitment to ethical practices. Ultimately, the podcast aims to equip professionals in the pharma and biotech sectors with the knowledge and strategies needed to rebuild trust, strengthen relationships, and create more resilient and successful businesses in an era of significant public scrutiny.